was read the article
array:23 [ "pii" => "S1579212917301143" "issn" => "15792129" "doi" => "10.1016/j.arbr.2016.10.005" "estado" => "S300" "fechaPublicacion" => "2017-06-01" "aid" => "1490" "copyright" => "SEPAR" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2017;53:355-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2083 "formatos" => array:3 [ "EPUB" => 158 "HTML" => 1472 "PDF" => 453 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0300289616302733" "issn" => "03002896" "doi" => "10.1016/j.arbres.2016.10.011" "estado" => "S300" "fechaPublicacion" => "2017-06-01" "aid" => "1490" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2017;53:355-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3845 "formatos" => array:3 [ "EPUB" => 129 "HTML" => 3193 "PDF" => 523 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científica</span>" "titulo" => "Toxicidad pulmonar después del tratamiento con lenalidomida en un paciente con mieloma múltiple" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "355" "paginaFinal" => "356" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Lung Toxicity after Lenalidomide Treatment in a Patient with Multiple Myeloma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 659 "Ancho" => 1500 "Tamanyo" => 84883 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Radiografía de tórax del paciente con infiltrados pulmonares bilaterales. B) TAC de tórax con afectación bilateral y difusa en vidrio deslustrado.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Eva Cabrera César, M. Carmen Fernández Aguirre, Antonio González Fernández" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Eva" "apellidos" => "Cabrera César" ] 1 => array:2 [ "nombre" => "M. Carmen" "apellidos" => "Fernández Aguirre" ] 2 => array:2 [ "nombre" => "Antonio" "apellidos" => "González Fernández" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212917301143" "doi" => "10.1016/j.arbr.2016.10.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301143?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616302733?idApp=UINPBA00003Z" "url" => "/03002896/0000005300000006/v2_201707150129/S0300289616302733/v2_201707150129/es/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S1579212917301222" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.04.008" "estado" => "S300" "fechaPublicacion" => "2017-06-01" "aid" => "1497" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2017;53:353-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1640 "formatos" => array:3 [ "EPUB" => 136 "HTML" => 1130 "PDF" => 374 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Pulmonary Disease Caused by <span class="elsevierStyleItalic">Mycobacterium szulgai</span>" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "353" "paginaFinal" => "354" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad pulmonar producida por <span class="elsevierStyleItalic">Mycobacterium szulgai</span>" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 686 "Ancho" => 950 "Tamanyo" => 67572 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Chest computed tomography: fibrocavitary tracts in both upper fields, with signs of air trapping, panlobular emphysema, nodular opacities in both lungs, and bilateral pleural thickening.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ana Milagro Beamonte, Elena Briz Muñoz, Luis Torres Sopena, Luis Borderías Clau" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Ana" "apellidos" => "Milagro Beamonte" ] 1 => array:2 [ "nombre" => "Elena" "apellidos" => "Briz Muñoz" ] 2 => array:2 [ "nombre" => "Luis" "apellidos" => "Torres Sopena" ] 3 => array:2 [ "nombre" => "Luis" "apellidos" => "Borderías Clau" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289616303246" "doi" => "10.1016/j.arbres.2016.11.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616303246?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301222?idApp=UINPBA00003Z" "url" => "/15792129/0000005300000006/v2_201707150125/S1579212917301222/v2_201707150125/en/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Lung Toxicity after Lenalidomide Treatment in a Patient with Multiple Myeloma" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "355" "paginaFinal" => "356" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Eva Cabrera César, M. Carmen Fernández Aguirre, Antonio González Fernández" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Eva" "apellidos" => "Cabrera César" "email" => array:1 [ 0 => "evacabreracesar@gmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "M. Carmen" "apellidos" => "Fernández Aguirre" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Antonio" "apellidos" => "González Fernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario Virgen de la Victoria, Málaga, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Hematología, Hospital Universitario Virgen de la Victoria, Málaga, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Toxicidad pulmonar después del tratamiento con lenalidomida en un paciente con mieloma múltiple" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 659 "Ancho" => 1500 "Tamanyo" => 84883 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Chest radiograph of patient with bilateral pulmonary infiltrates. (B) Chest computed tomography with bilateral, diffuse, ground glass involvement.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Multiple myeloma is the second most common cancer of the blood. Despite significant advances in treatment, it is considered an incurable disease, response to treatment is limited in duration, and the clinical course is generally relapsing. The combination of lenalidomide and dexamethasone is the therapeutic regimen of choice in relapse. Few cases of long-term lung toxicity presenting as organizing pneumonia in patients receiving this treatment have been reported in the literature. We report the case of a patient with a diagnosis of multiple myeloma, receiving lenalidomide, who developed dyspnea and pulmonary infiltrates. This is the first description of lenalidomide-induced lung toxicity in Spain.</p><p id="par0010" class="elsevierStylePara elsevierViewall">This was a 64-year-old man, former smoker, who was diagnosed with IgA kappa multiple myeloma in 2012. He initially received 6 cycles of bendamustine, Velcade<span class="elsevierStyleSup">®</span> and prednisone, in addition to autologous stem cell transplantation. In 2014, he relapsed, and began second-line treatment with monthly lenalidomide and dexamethasone.</p><p id="par0015" class="elsevierStylePara elsevierViewall">In 2015, he was admitted on 3 occasions with a diagnosis of pneumonia, treated with empirical antibiotics and short-term tapering corticosteroids. At the time of the last admission, he presented with a clinical picture of dyspnea, low-grade fever, and cough. The patient was admitted to the ward with a diagnosis of community-acquired pneumonia; PCR for influenza A and B, and antigens in blood for <span class="elsevierStyleItalic">Legionella</span> and pneumococcus were negative. Empirical treatment was started with levofloxacin, corticosteroids, and oxygen therapy.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Seven days after admission, coinciding with discontinuation of steroid treatment, the patient's clinical situation worsened, and he developed severe respiratory failure, and bilateral pulmonary infiltrates on chest radiograph, so a high-resolution CT (HRCT) was performed, showing extensive bilateral, diffuse, ground glass involvement, with patchy septal thickening and dilated bronchi (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) was performed, showing predominantly lymphocytic cellularity (with a CD4/CD8 ratio <0.9), and increased percentages of neutrophils and eosinophils. Microbiological cultures were negative. Transbronchial biopsy was not performed, given the worsening respiratory failure observed during the test.</p><p id="par0030" class="elsevierStylePara elsevierViewall">In view of these findings, the patient's clinical records were reviewed, showing previous episodes of pneumonia and administration of chemotherapy.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The relationship between treatment administration and onset of symptoms, HRCT findings and BAL results, as well as the improvement in symptoms after reintroduction of corticosteroids, led us to a diagnosis of lenalidomide-induced interstitial lung disease.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Lenalidomide is a less toxic and more potent immunomodulatory agent than thalidomide. It is indicated in the treatment of multiple myeloma relapses in combination with dexamethasone, and in other hematological diseases. Only 7 cases of lenalidomide-induced lung toxicity have been described in the literature.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">1–4</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">The mechanism of action of the drug is based on inhibition of prostaglandin E (PGE2). If PGE2 synthesis of the fibroblasts is affected in the lung, leukotriene mitogen activity is activated, triggering fibroblast proliferation and collagen synthesis, leading to interstitial lung disease.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">Another pathway that may cause lung disease may be an immunological response similar to that which occurs in patients with hypersensitivity pneumonitis.</p><p id="par0055" class="elsevierStylePara elsevierViewall">According to Zagouri et al.,<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> the onset of symptoms occurs 3–5 months after starting treatment. In our patient, symptoms began to appear 1 year after the first dose of lenalidomide.</p><p id="par0060" class="elsevierStylePara elsevierViewall">The treatment of choice is to discontinue the drug. The development of severe respiratory failure in our patient required the long-term use of corticosteroids.</p><p id="par0065" class="elsevierStylePara elsevierViewall">In conclusion, while lenalidomide-induced lung toxicity is a rare adverse effect, it should be considered in the differential diagnosis of patients receiving this drug who show symptoms of interstitial disease, after other alternative causes of lung disease have been ruled out.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Cabrera César E, Fernández Aguirre MC, González Fernández A. Toxicidad pulmonar después del tratamiento con lenalidomida en un paciente con mieloma múltiple. Arch Bronconeumol. 2017;53:355–356.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 659 "Ancho" => 1500 "Tamanyo" => 84883 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Chest radiograph of patient with bilateral pulmonary infiltrates. (B) Chest computed tomography with bilateral, diffuse, ground glass involvement.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Thornburg" 1 => "R. Abonour" 2 => "P. Smith" 3 => "K. Knox" 4 => "H.L. Twigg 3rd" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.06-1734" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2007" "volumen" => "131" "paginaInicial" => "1572" "paginaFinal" => "1574" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17494808" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lenalidomide-induced interstitial lung disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Y. Chen" 1 => "P. Kiatsimkul" 2 => "K. Nugent" 3 => "R. Raj" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1592/phco.30.3.325" "Revista" => array:5 [ "tituloSerie" => "Pharmacotherapy" "fecha" => "2010" "volumen" => "30" "paginaInicial" => "325" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20180616" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug-induced interstitial pneumonitis due to low-dose lenalidomide" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "K. Kunimasa" 1 => "T. Ueda" 2 => "M. Arita" 3 => "T. Maeda" 4 => "M. Hotta" 5 => "T. Ishida" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Intern Med" "fecha" => "2012" "volumen" => "51" "paginaInicial" => "1081" "paginaFinal" => "1085" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22576392" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of lenalidomide-induced hypersensitivity pneumonitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E. Lerch" 1 => "S. Györik" 2 => "J. Feilchenfeldt" 3 => "L. Mazzucchelli" 4 => "F. Quadri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000305213" "Revista" => array:6 [ "tituloSerie" => "Onkologie" "fecha" => "2010" "volumen" => "33" "paginaInicial" => "249" "paginaFinal" => "252" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20502059" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Zagouri" 1 => "M. Roussou" 2 => "E. Kastritis" 3 => "A. Koureas" 4 => "E. Tsokou" 5 => "M. Migkou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ajh.22135" "Revista" => array:6 [ "tituloSerie" => "Am J Hematol" "fecha" => "2011" "volumen" => "86" "paginaInicial" => "882" "paginaFinal" => "884" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21818766" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:3 [ "titulo" => "Acknowledgements" "texto" => "<p id="par0070" class="elsevierStylePara elsevierViewall">Our thanks to the Respiratory Medicine and Hematology Departments of the <span class="elsevierStyleGrantSponsor" id="gs1">Hospital Universitario Virgen de la Victoria</span>.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005300000006/v2_201707150125/S1579212917301143/v2_201707150125/en/main.assets" "Apartado" => array:4 [ "identificador" => "49861" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005300000006/v2_201707150125/S1579212917301143/v2_201707150125/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301143?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 3 | 8 | 11 |
2024 October | 70 | 19 | 89 |
2024 September | 62 | 17 | 79 |
2024 August | 71 | 44 | 115 |
2024 July | 44 | 22 | 66 |
2024 June | 82 | 26 | 108 |
2024 May | 91 | 30 | 121 |
2024 April | 58 | 28 | 86 |
2024 March | 63 | 18 | 81 |
2024 February | 34 | 26 | 60 |
2023 March | 20 | 3 | 23 |
2023 February | 86 | 14 | 100 |
2023 January | 98 | 46 | 144 |
2022 December | 77 | 38 | 115 |
2022 November | 79 | 28 | 107 |
2022 October | 95 | 43 | 138 |
2022 September | 63 | 23 | 86 |
2022 August | 116 | 44 | 160 |
2022 July | 87 | 44 | 131 |
2022 June | 76 | 39 | 115 |
2022 May | 88 | 32 | 120 |
2022 April | 98 | 28 | 126 |
2022 March | 109 | 46 | 155 |
2022 February | 94 | 29 | 123 |
2022 January | 115 | 34 | 149 |
2021 December | 93 | 41 | 134 |
2021 November | 103 | 47 | 150 |
2021 October | 79 | 48 | 127 |
2021 September | 51 | 47 | 98 |
2021 August | 69 | 36 | 105 |
2021 July | 44 | 32 | 76 |
2021 June | 77 | 43 | 120 |
2021 May | 87 | 45 | 132 |
2021 April | 190 | 71 | 261 |
2021 March | 108 | 35 | 143 |
2021 February | 66 | 25 | 91 |
2021 January | 70 | 26 | 96 |
2020 December | 63 | 23 | 86 |
2020 November | 53 | 30 | 83 |
2020 October | 115 | 13 | 128 |
2020 September | 119 | 20 | 139 |
2020 August | 107 | 18 | 125 |
2020 July | 86 | 23 | 109 |
2020 June | 78 | 20 | 98 |
2020 May | 100 | 11 | 111 |
2020 April | 63 | 21 | 84 |
2020 March | 38 | 12 | 50 |
2020 February | 57 | 16 | 73 |
2020 January | 56 | 24 | 80 |
2019 December | 69 | 15 | 84 |
2019 November | 60 | 28 | 88 |
2019 October | 53 | 16 | 69 |
2019 September | 56 | 16 | 72 |
2019 August | 58 | 19 | 77 |
2019 July | 62 | 15 | 77 |
2019 June | 53 | 12 | 65 |
2019 May | 69 | 24 | 93 |
2019 April | 60 | 27 | 87 |
2019 March | 51 | 27 | 78 |
2019 February | 41 | 23 | 64 |
2019 January | 35 | 17 | 52 |
2018 December | 44 | 30 | 74 |
2018 November | 104 | 31 | 135 |
2018 October | 143 | 18 | 161 |
2018 September | 44 | 19 | 63 |
2018 May | 15 | 1 | 16 |
2018 April | 43 | 7 | 50 |
2018 March | 23 | 10 | 33 |
2018 February | 51 | 12 | 63 |
2018 January | 92 | 9 | 101 |
2017 December | 73 | 7 | 80 |
2017 November | 25 | 10 | 35 |
2017 October | 20 | 12 | 32 |
2017 September | 37 | 14 | 51 |
2017 August | 0 | 1 | 1 |
2017 April | 1 | 1 | 2 |